Clinic meets Biology

West German Lymphoma Symposium

24th and 25th May 2024 | Essen

Programme

Day 1 | Friday, 24th May 2024

from 09:30

Registration

10:45

Welcome
Scientific committee

11:00-1:00

Session 1
The germinal center reaction as
a catalyst for lymphoma development

Chair

Christian Reinhardt
University Hospital Essen (GER)

11:00

Riccardo Dalla-Favera
Columbia University New York (USA)

11:25

Laura Pasqualucci
Columbia University New York (USA)

11:50

Ralf Küppers
University Hospital Essen (GER)

12:15

Dinis Calado
The Francis Crick Institute London (UK)

12:40

Short talk I

12:50

Discussion

1:00-2:00

Break

2:00-4:00

Session 2
Epigenetic rewiring as a driver
and target of lymphomagenesis

Chair

Peter Borchmann
University Hospital Cologne (GER)

2:00

Ari M. Melnick
Weill Cornell Medicine New York (USA)

2:25

Stefan Knapp
Goethe-University Frankfurt (GER)

2:50

Clemens Schmitt
Charité – University Hospital Berlin (GER)

3:15

Reiner Siebert
Ulm University Hospital (GER)

3:40

Short talk II

3:50

Discussion

4:00-6:00

Poster presentation and
Get together

Day 2 | Saturday, 25th May 2024

8:00-10:00

Session 3
Genetic rewiring encodes actionable
vulnerabilities in lymphoma

Chair

Sascha Dietrich
University Hospital Düsseldorf (GER)

8:00

Margaret Shipp
Dana Farber/Harvard Cancer Center
Boston (USA)

8:25

Louis Staudt
National Cancer Institute Bethesda (USA)

8:50

Björn Chapuy
Charité University Medicine Berlin (GER)

9:15

Thomas Oellerich
University Hospital Frankfurt (GER)

9:40

Short talk III

9:50

Discussion

10:00-10:30

Break

10:30-12:00

Session 2
Epigenetic rewiring as a driver
and target of lymphomagenesis

Chair

Peter Borchmann
University Hospital Cologne (GER)

02:00

Ari M. Melnick
Weill Cornell Medicine New York (USA)

02:25

Stefan Knapp
Goethe-University Frankfurt (GER)

02:50

Clemens Schmitt
Charité – University Hospital Berlin (GER)

03:15

Rainer Siebert
Ulm University Hospital (GER)

09:40

Short talk II

09:50

Discussion

10:30-12:30

Session 4
The next frontier: harnessing the
immune system for lymphoma therapy

Chair

Bastian von Tresckow
University Hospital Essen (GER)

10:30

Jason Westin
University of Texas MD
Anderson Cancer Center Houston (USA)

10:50

Wendy Béguelin
Weill Cornell Medicine New York, (USA)

11:10

Peter Borchmann
University Hospital Cologne (GER)

11:30

Elisabeth Budde
City of Hope National
Medical Center Duarte (USA)

11:50

Sascha Dietrich
University Hospital Düsseldorf (GER)

12:10

Discussion

12:30-1:30

Break

1:30-3:00

Session 5
Mechanisms of resistance and
definition of high-risk DLBCL

Chair

Ralf Küppers
University Hospital Essen (GER)

1:30

Ash A. Alizadeh
Stanford University /
Stanford Comprehensive Cancer Center (USA)

1:50

Andrew Davies
Southampton General Hospital (UK)

2:10

tba

2:10

Philipp Staber
Medical University of Vienna (AUT)

2:30

Christian Reinhardt
University Hospital Essen (GER)

2:50

Discussion

3:00

Closing remarks
Farewell and Goodbye

Status 12/2023, subject to change.